Microdosing

Joe Goelzhouser and Annie McGuire of Silver Assist talk about how they connect seniors and their families to the best resources, services and communities as they navigate their senior years.

Jessica Rhule of Creating Results talks about how they work closely with their clients’ sales teams to align their sales and marketing initiatives in order to exceed their occupancy goals.

Greg Gifford is SearchLab’s Vice President of Search. He’s one of the most popular speakers in the SEO industry and presents all over the world on topics related to Local SEO.

Jennifer Hines will be speaking at SMASH this year on “Starting your Post-Acute Consumer Marketing Machine”, and she touches on a variety of rapidly emerging needs for more active social media efforts, and a greater degree of marketing maturity in that space.

Jeff Gronemeyer, VP at Conversion Logix, talks about senior living’s huge heart, and their new book, “Dating Your Way to Full Occupancy”.

Dan Hutson, head of marketing at Priya Living and long-time SMASH Advisory Board member joins us on this episode to introduce us to all things SMASH and what to expect this year.  He also touches on his work at Priya Living which provides independent retirement communities people 65+, inspired by vibrant and colorful Indian culture.

SMASH is the leading sales and marketing conference for senior care.  In addition to speaking at the event, we'll be collecting stories from other speakers and attendees in this series of Microdosing.  

"Water water everywhere and not a drop to drink" can sometimes be applied to healthcare data.  It's in abundance, but it's fragmented.  How does the industry bring it all together?  Enter Datavant and Ciox, and why I love this new combo. Link referenced in the episode: https://datavant.com/resources/blog/the-fragmentation-of-health-data/

Siemens acquired Varian in 2021, with the in intent that the combined companies would create a unique, highly integrated portfolio of imaging, laboratory diagnostics, artificial intelligence and treatment for the global fight against cancer with significant potential for increased value creation.  We agree, and think it signals a new generation of holistic imaging.

In a recent interview with Modern Healthcare, Jason Gorevic - CEO Tealdoc Health, said:  “I think all the recent M&A is an example of our strategy that you can’t develop all the components brick by brick and assemble them in a way that is fast enough to stay ahead of the market and respond to consumer needs, and that’s part of the reason why we’ve been acquisitive historically....  W...

Walmart and UnitedHealth Group, two of the world's largest enterprises are teaming up to enable better care delivery through Walmart locations, beginning with many rural locations.  How might this reshape rural care as we know it?  

David Feinberg joined Cerner last year.  Cerner then was subsequently acquired by Oracle.  Oracle's founder and executive chairman, Larry Ellison, touts that Cerner is seeking to build a national EMR.  What does it all mean?  This episode takes a guess.    

Mark Cuban's "Cost Plus Drug Company" is on a mission to "disrupt the drug industry".  When a big name makes big promises the healthcare industry normally gets either excited or cringes.  However, I'm finding it's doing neither.  In this episode, we share some thoughts and opinions as to why that is.

Amazon's latest acquisition of One Medical is another example of the constant momentum it's bringing into healthcare.  I highlight how Amazon's entry into healthcare is showing greater potential than other non-healthcare players who are trying to break in.

While the healthcare community was chastising IBM for its Watson for Oncology solution last decade, what happened to the amazing healthcare data companies they acquired?  Well, they were set free this year, under the brand, Merative.  And what can we learn from the Watson Health days?

GE is in the process of splitting into three companies.  We explore why this is a good thing, and why it needs to be done.  

Jamil Rivers of Chrysalis Initiative talks outcome disparities within breast cancer, and striving to ensure every patient receives the care they deserve.

Donna Walthall of Dana Farber shares her ASCO observations as a fifteen-time attendee, celebrating Dana-Farber’s 75th anniversary

Tim Wolfe of Syapseshare their approach toward Real World Care and Applied Experience

Matthew Schulz, a Medical Science Liaison, shares his observations on this year’s ASCO session.

Chakra Chennubhotlaand Dusty Majumdar of SpIntellx explore the possibilities of empowering researchers and clinicians to unravel the hidden connections in the tumor microenvironment through deep profiling cell-cell communication patterns and spatial relationships.

Anthony Giordano of Sermo shares their latest efforts with the Oncologist community, as well as the impact of their "Run with Peter" charity that is funding cancer research.

Natalie Sacarakis of IQVIA shares how their Cell and Gene Therapy COE can address the unique logistics management and clinical operations challenges around one's CAGT asset and pipeline.

Chelsea Saurer of Kesem - an organization focused on families who have a member suffering from cancer- shares that their live summer camps have returned to in-person summer programming.  

Jen-Tang Lu of Vysioneer shares shares how they are using AI to unlock real-world guideline-based tumor response assessments, and improve clinical trials in that space.